Chu Brabois

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Diffuse large B-cell lymphoma1 trial
• Liver and biliary tract cancer1 trial
• Myelodysplastic syndromes1 trial

Phase

• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Federation Francophone de Cancerologie Digestive1 trial
• Groupe Francophone des Myelodysplasies1 trial
• The Lymphoma Academic Research Organisation1 trial

Running trials

• Recruiting

  Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

  NCT06271057· Phase 2· The Lymphoma Academic Research Organisation· Source

  Contact: Arnaud CAMPIDELLI

• Active, not recruiting

  A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

  NCT03223961· Phase 3· Groupe Francophone des Myelodysplasies· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diffuse large B-cell lymphoma1 recruiting

Closed trials

• Completed

  Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy

  NCT05665348· Phase 2/3· Federation Francophone de Cancerologie Digestive· Source